LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Cartilage Guilty of Causing Inflammation
Large Joints and Extremities

Cartilage Guilty of Causing Inflammation

September 30, 2014 1 min read Premium comments

Advertisement

Cartilage Guilty of Causing Inflammation
Source: Wikimedia Commons and school genius
Secondary

Cartilage is to blame after all. Once believed to be an innocent bystander in cases of rheumatoid arthritis, researchers in Melbourne, Australia, find that cartilage plays an active role in the destruction of joints.

As reported by Allan Gill of Medical Press, a team of researchers from the Walter and Eliza Hall Institute made the discovery while investigating the role of the protein SOCS3 in controlling inflammation. Arthritis causes pain and inflammation in joints and, over time, destroys the cartilage that lubricates and cushions the joints. Bones can even be remodeled by rheumatoid arthritis which leads to disfigurement and increased pain.

For a long time doctors thought that cartilage was a victim of a patient’s overzealous immune system. Then Tommy Liu, M.D., and his colleagues found that cartilage “participates in the production of inflammation-signaling chemicals and contributes to its own destruction, ” he said.

Liu’s study investigated how the molecules—known as suppressors of cytokine signaling (SOCS3) molecules—control the flow of chemical messages within and between cells. They also regulate inflammation in rheumatoid arthritis. When the researchers created a model that lacked SOCS3 molecules in the cartilage, they found that tissue degradation increased.

“Without SOCS3, cartilage cells produced enzymes that drove tissue degradation and increased inflammation by releasing signaling molecules that triggered an increased autoimmune response, ” Liu said. “We also found that cartilage could produce a protein called RANKL that triggers bone remodeling.”

Liu’s study revealed the fact that cartilage, itself, plays an active role in the progression of rheumatoid arthritis. There is no cure for the disease and few treatments are effective in slowing the progress of the ailment. But Liu is hopeful. “Targeting the action of these inflammatory chemical messages could boost the efficacy of current treatments, ” he said.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy